前药
纳米载体
阿霉素
药物输送
右旋糖酐
化学
两亲性
胶束
药品
体内
生物物理学
药理学
组合化学
化疗
共聚物
生物化学
有机化学
聚合物
医学
外科
生物技术
水溶液
生物
作者
Xiaoli Zhang,Ziqiang Tian,Xianbin Ma,Yajun Wang,Yi Lu,Die Jia,Xiaohua Huang,Jiucun Chen,Zhigang Xu,Feiqiu Wen
标识
DOI:10.1016/j.ajps.2019.10.001
摘要
Tumor cells show acidic conditions compared with normal cells, which further inspires scientist to build nanocarrier responsive to tumor microenvironment (TME) for enhancing tumor therapeutic efficacy. Here, we report a pH-sensitive and biocompatible polyprodrug based on dextran-doxorubicin (DOX) prodrug (DOXDT) for enhanced chemotherapy. High-density DOX component was covalently decorated on the nanocarrier and the drug molecules could be effectively released in the acidic tumor tissue/cells, improving chemotherapy efficacy. Specifically, a dextran-based copolymer was preliminarily prepared by one-step atom transfer radical polymerization (ATRP); then DOX was conjugated on the copolymer component via pH-responsive hydrazone bond. The structure of DOXDT can be well-controlled. The resulting DOXDT was able to further self-assemble into nanoscale micelles with a hydration diameter of about 32.4 nm, which presented excellent micellar stability. Compared to lipid-based drug delivery system, the DOXDT prodrug showed higher drug load capacity up to 23.6%. In addition, excellent stability and smaller size of the nanocarrier contributed to better tissue permeability and tumor suppressive effects in vivo. Hence, this amphipathic DOXDT prodrug is promising in the development of translational DOX formulations, which would be widely applied in cancer therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI